Skip to main content
. 2021 Oct 28;9(10):e003288. doi: 10.1136/jitc-2021-003288

Table 3.

Adverse events

Event Grade 1 Grade 2 Grade 3 Grade 4 Unknown Total Grade ≥3
Nausea 7 (38.9) 4 (22.2) 1 (5.6) 12 (66.7) 1 (5.6)
Appetite loss 2 (11.1) 4 (22.2) 5 (27.8) 11 (61.1) 5 (27.8)
Hiccup 4 (22.2) 7 (38.9) 11 (61.1)
Constipation 4 (22.2) 5 (27.8) 9 (50.0)
Rush 3 (16.7) 4 (22.2) 7 (38.9)
Anemia 4 (22.2) 3 (16.7) 7 (38.9) 3 (16.7)
Fatigue 2 (11.1) 4 (22.2) 6 (33.3)
Nasopharyngitis 3 (16.7) 2 (11.1) 5 (27.8)
Insomnia 4 (22.2) 1 (5.6) 5 (27.8)
Neutropenia 5 (27.8) 5 (27.8)
Diarrhea 1 (5.6) 3 (16.7) 4 (22.2)
Fever 4 (22.2) 4 (22.2)
Peripheral neuropathy 2 (11.1) 1 (5.6) 1 (5.6) 4 (22.2) 1 (5.6)
Leukopenia 3 (16.7) 1 (5.6) 4 (22.2) 1 (5.6)
Mucositis 3 (16.7) 3 (16.7)
Pneumonia 2 (11.1) 1 (5.6) 3 (16.7) 1 (5.6)
Dysgeusia 1 (5.6) 1 (5.6) 1 (5.6) 3 (16.7)
Hearing impairment 2 (11.1) 1 (5.6) 3 (16.7)
Abdominal discomfort 1 (5.6) 1 (5.6) 2 (11.1)
Angular cheilitis 1 (5.6) 1 (5.6) 2 (11.1)
Hyponatremia 1 (5.6) 1 (5.6) 2 (11.1) 2 (11.1)
Muscle pain 1 (5.6) 1 (5.6)  2 (11.1)
Back pain 1 (5.6) 1 (5.6)  2 (11.1) 1 (5.6)

Values are n (%).